Albemarle

Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential

AnalystConsensusTarget

Not Invested

Consensus Narrative from 22 Analysts

Published

22 Apr 25

Updated

15 Aug 25

AnalystConsensusTarget's Fair Value

US$82.88

0.8% undervalued

15 Aug

US$82.19

3.6%

8.9%

Author's Valuation

US$82.9

0.8% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates1

Shared on01 May 25
Fair value Increased 0.41%

AnalystConsensusTarget Fair Value

US$82.9

0.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

9.09%

Chemicals revenue growth rate

0.35%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.03%

Calculation

US$1.07b

Earnings '28

11.53x

PE Ratio '28

US$12.33b

Market Cap '28

US$12.33b

Market Cap '28

118.13m

No. shares '28

US$104.37

Share Price '28

US$104.37 Share Price '28

Discounted to 2025 @ 8.03% p.a.

US$82.78

Fair Value '25

Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential

Shared on01 May 25Fair value Increased 0.41%

Shared on01 May 25
Fair value Increased 0.41%